RCE · Recce Pharmaceuticals Ltd.
0.51
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$141.70M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
N/A
MQV Rating
5Very Weak
As at 17/06/2026 04:10:10 PM
Price Chart
Description
- All-Companies
- All-Consensus
- EMA 125 Breakdown
- Fakey Shakey - Long
- Fakey Shakey - Long (Realtime)
- GROWTH AUS
- HALO Capital Efficiency
- HALO Consensus Value
- HALO Earnings Momentum
- HALO Momentum
- HALO Ords
Key Fundamentals
EPS 3 yr Growth
46.00%
EBITDA Margin
N/A
Operating Cashflow
-$20m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-21.90
Quick Ratio
1.90
Performance
52 weeks range
Low 0.28 - 0.73
Trade Value (12mth)
AU$14,324.00
1 week
-2.94%
1 month
5.32%
YTD
-25.84%
1 year
65%
All time high
1.84
Additional Data
Shares Outstanding (Fully Diluted)
289m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Neutral
Earnings
Very Strong
Growth
Earnings
Strong
Dividends
Very Weak
Quality
Capital Efficiency
Very Strong
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
27 May 26ASXD | |
27 May 26ASXD | |
30 April 26ASXD | |
21 April 26ASXD | |
15 April 26ASXD |
